Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Completed · Phase 2

Conditions studied: Bladder Cancer

In brief

To combine oxaliplatin and taxotere in patients who have had prior cisplatin therapy in bladder cancer.

Key facts

Study ID

NCT00186277

Run by

Stanford University

People needed

10

Starts

2003-12-01

Expected to finish

2006-12-01

Last updated by the study team

2011-03-30

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.